CT-guided Thermal Ablation of Liver Tumors Using Intraprocedural CT-CT Fusion for Applicator Position and Ablation Completeness Assessment: a Single-Center Comparative Analysis
- PMID: 40640410
- DOI: 10.1007/s00270-025-04111-w
CT-guided Thermal Ablation of Liver Tumors Using Intraprocedural CT-CT Fusion for Applicator Position and Ablation Completeness Assessment: a Single-Center Comparative Analysis
Abstract
Purpose: To compare outcomes of CT-guided thermal ablation of liver tumors with versus without use of intraprocedural CT-CT image fusion.
Materials and methods: This retrospective cohort study included all patients treated with CT-guided percutaneous thermal ablation for hepatocellular carcinoma (HCC) or colorectal liver metastases (CRLM) between January 2017 and April 2023 at our institution. From October 2019, intraprocedural CT-CT deformable image fusion (IF) using dedicated software (Vitrea, Canon Medical) was introduced to the thermal ablation procedure workflow to visually assess applicator placement before ablation and ablation completeness posttreatment. Local tumor progression (LTP) was assessed on follow-up imaging. LTP-free survival (LTPFS) between groups with and without IF was estimated with the Kaplan-Meier method and risk factors for LTP were identified with Cox regression analysis.
Results: A total of 113 patients treated in 139 sessions were included; 66 treatments for 86 tumors without use of IF (56 HCC; 30 CRLM) and 73 treatments for 92 tumors with use of IF (46 HCC; 46 CRLM). Two-year LTPFS was significantly improved with use of IF for both HCC (97% vs. 74%; p = .009) and CRLM (82% vs. 56%; p = .033). On univariate regression analysis, use of IF was a predominant factor significantly associated with improved LTPFS in patients with HCC (HR: 0.21, p = .037) and CRLM (HR: 0.38, p = .042).
Conclusion: In this single-center study, the use of software-based intraprocedural CT-CT image fusion for applicator position and ablation completeness assessment was associated with improved local tumor progression-free survival after CT-guided thermal ablation of HCC and CRLM.
Keywords: Image fusion; Liver malignancies; Local tumor progression-free survival (LTPFS); Thermal ablation.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of interest: J.H.W. de Wilt received grants to his institution, not related to this research from Dutch Cancer Society, ZONMW, Roche, Medtronic. The other authors declare that they have no conflict of interest. Ethical Approval: For this type of study, formal consent is not required. Informed Consent: This study has obtained IRB approval from the local institutional review board of Radboudumc and the need for informed consent was waived. Consent for Publication: For this type of study, consent for publication is not required.
Similar articles
-
Ablative margin quantification using deformable versus rigid image registration in colorectal liver metastasis thermal ablation: a retrospective single-center study.Eur Radiol. 2024 Sep;34(9):5541-5550. doi: 10.1007/s00330-024-10632-8. Epub 2024 Feb 9. Eur Radiol. 2024. PMID: 38334762 Free PMC article.
-
Impact of Tumor Size on Outcomes of Hepatic Arteriography and C-Arm CT-Guided Ablation (HepACAGA): > 3 cm Is No Absolute Contraindication.Cardiovasc Intervent Radiol. 2025 Aug 26. doi: 10.1007/s00270-025-04167-8. Online ahead of print. Cardiovasc Intervent Radiol. 2025. PMID: 40859002
-
Ultrasound guidance versus CT guidance with stereotactic navigation in thermal ablation for hepatocellular carcinoma: A comparative retrospective analysis.Eur J Surg Oncol. 2025 Jun 26;51(9):110292. doi: 10.1016/j.ejso.2025.110292. Online ahead of print. Eur J Surg Oncol. 2025. PMID: 40617122
-
Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.Health Technol Assess. 2023 Dec;27(29):1-172. doi: 10.3310/GK5221. Health Technol Assess. 2023. PMID: 38149643 Free PMC article.
-
Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.Cochrane Database Syst Rev. 2017 Mar 28;3(3):CD011650. doi: 10.1002/14651858.CD011650.pub2. Cochrane Database Syst Rev. 2017. PMID: 28351116 Free PMC article.
References
-
- Tinguely P, Ruiter SJS, Engstrand J, et al. A prospective multicentre trial on survival after Microwave Ablation VErsus Resection for Resectable Colorectal liver metastases (MAVERRIC). Eur J Cancer. 2023;187:65–76. - PubMed
-
- Bai XM, Cui M, Yang W, et al. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC. Radiology. 2021;300(2):458–69. - PubMed
-
- Takahashi H, Kahramangil B, Berber E. Local recurrence after microwave thermosphere ablation of malignant liver tumors: results of a surgical series. Surgery. 2018;163(4):709–13. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous